Your session is about to expire
← Back to Search
Other
Caffeine for Labor Management
Phase 1
Waitlist Available
Led By Daniel Jiang, MD
Research Sponsored by The Reading Hospital and Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
Study Summary
This trial tests if caffeine & sodium benzoate can help reduce labor time in the 2nd stage of childbirth.
Who is the study for?
This trial is for first-time pregnant mothers at term (37 weeks or more), who have a way to receive medications through their veins. It's not suitable for those with certain conditions that aren't listed here.Check my eligibility
What is being tested?
The study is testing if an injection of caffeine and sodium benzoate can help during the second stage of labor, when the mother pushes out the baby. Participants are randomly given either this injection or a normal saline solution without knowing which one they received.See study design
What are the potential side effects?
Possible side effects from caffeine and sodium benzoate injection may include restlessness, heart palpitations, dizziness, and insomnia. Normal saline typically has no side effects but might cause mild irritation at the injection site.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in maternal blood loss
Shortened second stage of labor
Secondary outcome measures
Fetal APGAR score
Incidence of operative delivery
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Caffeine and sodium benzoateExperimental Treatment1 Intervention
Patients will received 250 mg IV caffeine and sodium benzoate (125 mg each) dissolved in 500 cc normal saline which will be administered over the course of two hours upon determination the patient is 10 cm in cervical dilation.
Group II: PlaceboPlacebo Group1 Intervention
Patients will received 500 cc normal saline which will be administered over the course of two hours upon determination the patient is 10 cm in cervical dilation.
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
The Reading Hospital and Medical CenterLead Sponsor
13 Previous Clinical Trials
1,456 Total Patients Enrolled
Daniel Jiang, MDPrincipal InvestigatorReading Hospital Tower Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of serious heart conditions.I have a history of high blood pressure or related conditions.I have a history of liver problems, including fatty liver, cirrhosis, or high liver enzymes.I am a pregnant woman at or past 37 weeks, aged 18-45, with an IV line.
Research Study Groups:
This trial has the following groups:- Group 1: Caffeine and sodium benzoate
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being accepted into this experiment presently?
"The listing on clinicaltrials.gov denotes that this particular medical study is not currently recruiting, having been posted August 1st 2023 and updated June 21st 2023. Nevertheless, two other trials are presently enrolling research participants."
Answered by AI
Has the Federal Drug Administration sanctioned Caffeine and sodium benzoate?
"As the trial is now in Phase 1, our internal evaluation of Caffeine and sodium benzoate's safety scored a 1 due to sparse data confirming its efficacy."
Answered by AI
Share this study with friends
Copy Link
Messenger